Wegovy is licensed for weight management treatment, whereas Rybelsus and Ozempic are licensed for use in type 2 diabetes patients
Instead, it delivers potent anti-inflammatory effects without the side effects typically seen with steroid treatments
Your current page already cites the most important trials SURMOUNT-1, SURPASS-2 and related diabetes work which is exactly the right evidence base for this section
They either used exenatide injections on a weekly basis, or a visually identical placebo
Many patients may report an increase in energy and a decrease in fatigue after starting B-complex injections, usually within days to a couple of weeks of regular treatment
2 GLP-1 RAs, such as semaglutide, also show potential anti-inflammatory properties